DRKS00025961
Recruiting
未知
Prevention of Medication Overuse (MO) and Medication Overuse Headache (MOH): A randomized, controlled, parallel, multicenter, prospective trial using a mobile application software - MOH
niversitätsklinikum Essen in Wahrnehmung der Aufgaben der Universität Duisburg-Essen, Campus Essen, Fachbereich Medizin; Institution: Institut für Medizinische Informatik, Biometrie und Epidemiologie0 sites960 target enrollmentAugust 4, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- G43
- Sponsor
- niversitätsklinikum Essen in Wahrnehmung der Aufgaben der Universität Duisburg-Essen, Campus Essen, Fachbereich Medizin; Institution: Institut für Medizinische Informatik, Biometrie und Epidemiologie
- Enrollment
- 960
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Migraine patients: Patients with frequent episodic migraine (EM) (\= 8\-14 headache days/month, of which 4 fulfill IHS criteria for migraine) or chronic migraine (CM) (\=15 headache days/month, of which 8 fulfill IHS criteria for migraine)
- •Post\-MO(H)\-Patients: Patients, who underwent treatment for MO(H) (initially \= 15 headache days/month, intake of attack aborting medication on 10 or more or 15 or more days/month according to International Classification of Headache Disorders (ICHD\-3\) criteria of mediation overuse headache (MOH))
- •2\) Owning a mobile device with iOS or Android system, which is able to run the App
- •3\) Adults \= 18 years
- •4\) Written informed consent consistent with ICH\-GCP (International Conference of Harmonization – Good Clinical Practice) guidelines and local laws signed prior to all study\-related procedures
- •5\) Compliance for using the App on \= 80% days during the screening period
Exclusion Criteria
- •1\) Patients with concomitant primary headache disorders, other than EM or CM (except tension\-type headache \< 15 days/month)
- •2\) Current MO upon the discretion of the treating physician (intake of attack aborting medication on \=10 days/month within the last 3 months)
- •3\) Co\-morbidity interfering with the study outcomes upon the discretion of the treating physician
- •4\) Intake of opioids on \> 3 days/month
- •5\) Regular intake (\> 15 days/month) of (i) hypnotics, (ii) benzodiazepines as sedatives (tranquillizer), (iii) antipsychotics (neuroleptics) in psychiatric indication
- •6\) Parallel use of other migraine apps to track headache days and medication intake
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Medication management and preventive healthcare for adults with intellectual disabilitiesF70-F79Mental retardationDRKS00014101Hochschule für angewandte Wissenschaften Hamburg, Fakultät Wirtschaft und Soziales, Department Pflege und Management164
Completed
Not Applicable
Medication Management and Medication-Related Problems in People with Chronic Liver DiseaseDecompensated liver cirrhosisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12616000780459The University of Queensland120
Active, not recruiting
Not Applicable
Evaluation of a clinical service to support the uptake of breast cancer prevention medications by women at increased risk of the diseasePrevention of breast cancer in clients at increased riskCancerISRCTN15718519Peter MacCallum Cancer Centre250
Completed
Not Applicable
Reduction of potentially inappropriate medication in the elderypotentially inappropriate medication in the elderly (no specific disease or condition necessary for study inclucion)DRKS00003610Ruhr-Universität Bochum1,275
Not yet recruiting
Not Applicable
Evaluation of Medication Usage trend and medication use Behavior among the patients with acneHealth Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2024/07/071536I